These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 18649911)

  • 1. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
    Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
    Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
    Armstrong DJ; Roman A
    Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of transformation by the human papillomaviruses.
    Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
    Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.
    Caldeira S; de Villiers EM; Tommasino M
    Oncogene; 2000 Feb; 19(6):821-6. PubMed ID: 10698500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.
    Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A
    Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle.
    Mansour M; Touka M; Malena A; Indiveri C; Dong W; Gionfriddo I; Accardi R; Paradiso A; Sylla BS; Gabet AS; Tommasino M
    Cancer Lett; 2007 Feb; 246(1-2):274-81. PubMed ID: 16650526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.
    Alunni-Fabbroni M; Littlewood T; Deleu L; Caldeira S; Giarrè M; Dell' Orco M; Tommasino M
    Oncogene; 2000 May; 19(19):2277-85. PubMed ID: 10822378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
    Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
    Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.
    Mansour M; Touka M; Hasan U; Bellopede A; Smet A; Accardi R; Gabet AS; Sylla BS; Tommasino M
    Virology; 2007 Oct; 367(1):1-9. PubMed ID: 17568647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
    Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
    Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha.
    Boccardo E; Manzini Baldi CV; Carvalho AF; Rabachini T; Torres C; Barreta LA; Brentani H; Villa LL
    Carcinogenesis; 2010 Mar; 31(3):521-31. PubMed ID: 20042637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of E7/Rb associations.
    Caldeira S; Dong W; Tommasino M
    Methods Mol Med; 2005; 119():363-79. PubMed ID: 16350411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
    Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
    PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
    Avvakumov N; Torchia J; Mymryk JS
    Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E7 proteins from high- and low-risk human papillomaviruses bind to TGF-beta-regulated Smad proteins and inhibit their transcriptional activity.
    Habig M; Smola H; Dole VS; Derynck R; Pfister H; Smola-Hess S
    Arch Virol; 2006 Oct; 151(10):1961-72. PubMed ID: 16710631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha interferes with the cell cycle of normal and papillomavirus-immortalized human keratinocytes.
    Vieira KB; Goldstein DJ; Villa LL
    Cancer Res; 1996 May; 56(10):2452-7. PubMed ID: 8625327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A; Schmidt D; Müller S
    Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells.
    Reznikoff CA; Yeager TR; Belair CD; Savelieva E; Puthenveettil JA; Stadler WM
    Cancer Res; 1996 Jul; 56(13):2886-90. PubMed ID: 8674033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL; Yee CL; Münger K
    Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages.
    Banks L; Moreau F; Vousden K; Pim D; Matlashewski G
    J Immunol; 1991 Mar; 146(6):2037-42. PubMed ID: 1848576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.